Announcements Trials
Browse Landscape

Phase

Phase 3 32Phase NA 18Phase 2 16Phase 4 2Phase 1/2 2Phase 1 2Phase EARLY_PHASE1 1

Status

Recruiting 3Completed 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 134Neoplasms 112Polycystic Ovary Syndrome 66Prostatic Neoplasms 63Colorectal Neoplasms 51Carcinoma, Non-Small-Cell Lung 47Pain 40Carcinoma, Hepatocellular 35Lung Neoplasms 34Keratosis, Actinic 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Pain, Postoperative 26Neoplasm Metastasis 26Head and Neck Neoplasms 26Stomach Neoplasms 24Colonic Neoplasms 23Multiple Myeloma 22Brain Neoplasms 21Pancreatic Neoplasms 20Lymphoma, Follicular 19Leukemia 19Anemia 19Uterine Cervical Neoplasms 18Leukemia, Myeloid, Acute 18Infertility 18Leiomyoma 17Lymphoma, Non-Hodgkin 16Lymphoma 16Cancer Pain 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15

Interventions

Immunoglobulins, Intravenous 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Completed × Myasthenia Gravis × Clear all
NCT00987116 2017-10-13

MYACOR

Assistance Publique - Hôpitaux de Paris

Phase 4 Completed
118 enrolled

Myasthenia Gravis

NCT01179893 2010-08-11

Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis

University Health Network, Toronto

Phase 4 Completed
87 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡